Institutional Ownership Context Therapeutics Inc. (CNTX)
This table provides information about the institutional ownership of Context Therapeutics Inc. (CNTX). We have compiled data on the 55 institutions that hold shares in the stock, with a total of 72.9 Million shares, which have been reported (via 13F filing form) to have a value of $62 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
14,705,882
shares
|
$11.9 Million
2.18% of portfolio
|
Q4 2024
New holding
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
7,477,200
shares
|
$6.06 Million
0.84% of portfolio
|
Q4 2024
Added 0.81%
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
7,419,355
shares
|
$6.01 Million
0.32% of portfolio
|
Q2 2024
New holding
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
7,419,355
shares
|
$6.01 Million
1.37% of portfolio
|
Q2 2024
New holding
|
|
Blue Owl Capital Holdings LP
New York, NY |
Feb 14, 2025 Q4 2024 |
6,357,928
shares
|
$5.15 Million
2.69% of portfolio
|
Q4 2024
Added 17.49%
|
|
Great Point Partners LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
4,683,711
shares
|
$3.79 Million
3.06% of portfolio
|
Q4 2024
Reduced 32.46%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
4,003,380
shares
|
$3.24 Million
0.0% of portfolio
|
Q4 2024
Added 115.93%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,255,463
shares
|
$2.64 Million
0.0% of portfolio
|
Q4 2024
Reduced 13.07%
|
|
Blackstone Inc
New York, NY |
Feb 14, 2025 Q4 2024 |
2,440,330
shares
|
$1.98 Million
0.01% of portfolio
|
Q3 2024
Added 32.72%
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
1,935,484
shares
|
$1.57 Million
0.1% of portfolio
|
Q2 2024
New holding
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,663,355
shares
|
$1.35 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.02%
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,576,762
shares
|
$1.28 Million
1.77% of portfolio
|
Q4 2024
Reduced 10.29%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,361,350
shares
|
$1.1 Million
0.01% of portfolio
|
Q4 2024
Added 0.05%
|
|
Sio Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,328,352
shares
|
$1.08 Million
0.49% of portfolio
|
Q2 2024
New holding
|
|
Affinity Asset Advisors, LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
1,015,340
shares
|
$822,425
0.18% of portfolio
|
Q4 2024
Reduced 23.15%
|
|
Allostery Investments LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
950,166
shares
|
$769,634
1.04% of portfolio
|
Q4 2024
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
851,696
shares
|
$689,873
0.0% of portfolio
|
Q2 2024
New holding
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
699,129
shares
|
$566,294
0.0% of portfolio
|
Q4 2024
Added 40618.05%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
628,729
shares
|
$509,270
0.0% of portfolio
|
Q4 2024
Added 9.17%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
351,094
shares
|
$284,386
0.07% of portfolio
|
Q4 2024
Reduced 6.08%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
338,435
shares
|
$274,132
0.0% of portfolio
|
Q4 2024
Added 412.78%
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
322,838
shares
|
$261,498
0.0% of portfolio
|
Q4 2024
Added 212.21%
|
|
Ubs Oconnor LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
308,758
shares
|
$250,093
0.02% of portfolio
|
Q3 2024
Added 5.11%
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
203,286
shares
|
$164,661
0.0% of portfolio
|
Q4 2024
New holding
|
|
Swisspartners Ltd.
Vaduz, N2 |
Feb 14, 2023 Q4 2022 |
180,000
shares
|
$145,800
0.15% of portfolio
|
Q4 2022
Added 111.76%
|